Matthew Fury, MD
Orthopaedic Surgery · Gonzales, LANPI 1518495381
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (44.9%), education and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 49.0% of the total. Reporting peaked in 2022 at $24,696 and has fallen 97.0% since, to $745 in 2025.
Across 90 payments — averaging $424.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$19K
- Smith+Nephew$14K
- Stryker$2K
- Kairos Surgical Inc$1K
- Exactech, Inc.$931
- ALON Medical Technology$597
- plus $979 from 12 others
What the payments were for
- Grants$17,14345%
- Travel & lodging$1,7625%
- Food & beverage$4,03911%
- Education$15,22540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 23 | $18,706 |
| Smith+Nephew | 5 | $14,332 |
| Stryker | 30 | $1,525 |
| Kairos Surgical Inc | 3 | $1,099 |
| Exactech, Inc. | 4 | $931 |
| ALON Medical Technology | 7 | $597 |
| Innovation Technologies Inc | 2 | $324 |
| Next Science LLC | 1 | $125 |
| Abanza Inc. | 1 | $121 |
| Johnson & Johnson | 2 | $91 |
| Suvon Surgical LLC | 2 | $91 |
| Vericel Corporation | 3 | $62 |
| Amgen | 2 | $39 |
| Biocomposites Inc | 1 | $33 |
| Bioventus LLC | 1 | $27 |
| Dynasplint Systems Inc. | 1 | $26 |
| Atland Pharmaceuticals, LLC | 1 | $25 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EQUINOXE$905
- Irrisept$324
- MAKO$322
- AEQUALIS ASCEND FLEX$158
- Healicoil$146
- Bioinductive Implant with Arthroscopic Delivery System - Medium$146
- NANOTACK FLEX$128
- SurgX$125
- Xperience$125
- BlastX$125
- WasherCap Fixation System 10mm$121
- WasherCap Mini Fixation system 4.5mm$121
- Bone Anchors with Arthroscopic Delivery System$116
How this compares
$38,169 in reported general payments places this provider in the 85th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 29 | $231 |
| Ketorolac Tromethamine | 15 | $210 |
| Oxycodone Hcl | 33 | $165 |
| Meloxicam | 49 | $107 |
| Gabapentin | 23 | $89 |
| Ondansetron Hcl | 26 | $88 |
| Tramadol Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gonzales
- Christopher HarrodBaton Rouge$3M
- Vinod DasaKenner$1.9M
- Pierce NunleyShreveport$1.8M
- Jorge IsazaBaton Rouge$1.2M
- Neil MakiThibodaux$620K
- Robert ZuraNew Orleans$597K
- Kevin McCarthyBaton Rouge$594K
- Timmothy RandellAlexandria$498K
- Fernando SanchezNew Orleans$484K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.